Close Menu

NEW YORK – HTG Molecular Diagnostics said in a regulatory document on Thursday that it may offer up to $20 million in shares of its common stock from time to time.

It also signed a sales agreement with Cantor Fitzgerald for the possible sale of the shares, the Tucson, Arizona-based molecular profiling firm said in a document filed with the US Securities and Exchange Commission. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.